Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Olmstead

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Drug and Alcohol Dependence|May 16, 2015
Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, CanadaEvan B Cunningham, Brendan Jacka, Kora DeBeck, et al.
Viruses|November 11, 2022
Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort StudyAndrea D Olmstead, Aidan M Nikiforuk, Sydney Schwartz, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 18, 2019
A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infectionsAndrea D Olmstead, Vincent Montoya, Celia K Chui, et al.
Cancer Research|January 29, 2024
Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid LeukemiaAndrew J Monteith, Haley E Ramsey, Alexander J Silver, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in miceTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Nature|March 28, 2022
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeuticTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Emerging Microbes & Infections|August 9, 2023
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariantsJimena Pérez-Vargas, Liam J Worrall, Andrea D Olmstead, et al.
Cancer Discovery|October 1, 2025
Elevated Clonal Hematopoiesis in 9/11 First Responders Has Distinct Age-related Patterns and Relies on IL1RAP for Clonal ExpansionDivij Verma, Rachel Zeig-Owens, David G Goldfarb, et al.
Antiviral Research|December 12, 2022
Discovery of lead natural products for developing pan-SARS-CoV-2 therapeuticsJimena Pérez-Vargas, Tirosh Shapira, Andrea D Olmstead, et al.
Antiviral Research|March 31, 2023
Corrigendum to "Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics" "Antiviral Research 209 (2023)/105484"Jimena Perez-Vargas, Tirosh Shapira, Andrea D Olmstead, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Drug and Alcohol Dependence|May 16, 2015
Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, CanadaEvan B Cunningham, Brendan Jacka, Kora DeBeck, et al.
Viruses|November 11, 2022
Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort StudyAndrea D Olmstead, Aidan M Nikiforuk, Sydney Schwartz, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 18, 2019
A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infectionsAndrea D Olmstead, Vincent Montoya, Celia K Chui, et al.
Cancer Research|January 29, 2024
Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid LeukemiaAndrew J Monteith, Haley E Ramsey, Alexander J Silver, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in miceTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Nature|March 28, 2022
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeuticTirosh Shapira, I Abrrey Monreal, Sébastien P Dion, et al.
Emerging Microbes & Infections|August 9, 2023
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariantsJimena Pérez-Vargas, Liam J Worrall, Andrea D Olmstead, et al.
Cancer Discovery|October 1, 2025
Elevated Clonal Hematopoiesis in 9/11 First Responders Has Distinct Age-related Patterns and Relies on IL1RAP for Clonal ExpansionDivij Verma, Rachel Zeig-Owens, David G Goldfarb, et al.
Antiviral Research|December 12, 2022
Discovery of lead natural products for developing pan-SARS-CoV-2 therapeuticsJimena Pérez-Vargas, Tirosh Shapira, Andrea D Olmstead, et al.
Antiviral Research|March 31, 2023
Corrigendum to "Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics" "Antiviral Research 209 (2023)/105484"Jimena Perez-Vargas, Tirosh Shapira, Andrea D Olmstead, et al.
Pageof 4